Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Prediction: Eli Lilly Will Be Worth More Than Berkshire Hathaway by 2030
05:10am, Saturday, 08'th Nov 2025
Eli Lilly has plenty of medium-term catalysts that should power a strong performance through 2030. Berkshire Hathaway, by contrast, is facing some headwinds that may limit its upside.
Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Here's What This Means for Investors.
03:45am, Saturday, 08'th Nov 2025
Eli Lilly struck a deal with President Donald Trump, lowering the prices of its blockbuster weight loss drugs. In return, Lilly gains exemption from import tariffs and other benefits.
On Thursday, Eli Lilly and Co. (NYSE:LLY) released data from a Phase 2 trial evaluating the safety and efficacy of eloralintide, an investigational once-weekly, selective amylin receptor agonist, in 2
Lilly's obesity drug Mounjaro becomes India's top-selling drug by value in October
12:51am, Friday, 07'th Nov 2025
Eli Lilly's blockbuster obesity drug Mounjaro became India's top-selling drug by value for the month of October with sales hitting 1 billion rupees ($11.38 million), research firm Pharmarack said on F
Eli Lilly expects US FDA approval for oral obesity drug in March 2026
04:48pm, Thursday, 06'th Nov 2025
Eli Lilly expects the U.S. Food and Drug Administration to approve its experimental oral obesity drug, orforglipron, by March 2026, its chief executive said on Thursday.
Lilly announces two new Executive Committee members and expansion of leadership roles to prepare for next wave of growth
04:05pm, Thursday, 06'th Nov 2025
INDIANAPOLIS , Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of two new Executive Committee members and the expansion of other senior leaders' roles de
Here's how much weight loss drugs could cost you under Trump's deals with Eli Lilly, Novo Nordisk
02:42pm, Thursday, 06'th Nov 2025
President Donald Trump struck landmark deals with Eli Lilly and Novo Nordisk to slash the prices of their blockbuster weight loss drugs. Under the agreements, the monthly out-of-pocket cost of popul
Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans
01:54pm, Thursday, 06'th Nov 2025
Medicare beneficiaries with obesity or overweight will have access to Zepbound and orforglipron, if approved, at $50 a month INDIANAPOLIS , Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:�
Lilly, Novo Will Lower Obesity Drug Prices in Trump Deal
01:02pm, Thursday, 06'th Nov 2025
Eli Lilly & Co. and Novo Nordisk A/S cut a deal with the Trump administration to lower prices on their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patie
President Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices
12:49pm, Thursday, 06'th Nov 2025
President Donald Trump announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of their obesity drugs, including upcoming pills, in a landmark effort to expand access to the costly
Lilly's experimental drug shows promise with 20.1% weight loss in mid-stage trial
06:49am, Thursday, 06'th Nov 2025
Eli Lilly said on Thursday its experimental obesity drug helped patients lose as much as 20.1% of their weight in a mid-stage trial.
Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study
06:45am, Thursday, 06'th Nov 2025
Eli Lilly said it will start late-stage trials on its experimental amylin obesity drug next month after it showed encouraging results in a mid-stage study. The highest dose of the weekly injection, ca
Based on these trial results, Lilly will begin enrolling Phase 3 clinical studies for the treatment of obesity next month INDIANAPOLIS , Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY)
Novo, Lilly shares rise as Trump obesity drug deal nears
06:40am, Thursday, 06'th Nov 2025
Shares of obesity drugmakers Eli Lilly and Novo Nordisk rose early on Thursday in anticipation of a White House deal that would reduce prices of their blockbuster weight-loss treatments in return for
Trump, Eli Lilly to announce weight loss drug price cut on Thursday, CBS reports
01:16pm, Wednesday, 05'th Nov 2025
U.S. President Donald Trump on Thursday is expected to announce a deal with officials from Eli Lilly and Novo Nordisk cutting the price of weight loss drugs in some cases to $150 a month, CBS reported
